Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Biotron Limited Rights Issue

Non-Renounceable Rights Issue Prospectus (November 2025)

Rounding of fractions of attaching options

Dispatch of prospectus and offer open

Application for quotation of securities

Notification of issue, conversion or payment up of unquoted equity securities

Notification of issue, conversion or payment up of unquoted equity securities

Completion of Tranche 2 of Placement

Completion of acquisition of Sedarex Limited

Appendix 3G – Notification of issue, conversion or payment up of unquoted equity securities

Appendix 2A – Application for quotation of securities

Appendix 2A – Application for quotation of securities

Appendix 2A – Application for quotation of securities

Completion of the Entitlement Offer

 

© Biotron Limited 2016       ABN 60 086 399 144        Site updated 23 December 2025        Legal Notices and Privacy
Cleantalk Pixel